Teikoplanina BRADEX

GIF decision: Marketing suspension

What does this decision mean?

  • Wstrzymanie w obrocie — The product has been temporarily suspended from circulation — sales are paused pending clarification, but it is not a full market recall.

Tests by the National Medicines Institute showed failure to meet specification requirements for subvisible particulate contamination (negative result for particles ≥10 μm) and non-compliance of the reconstituted solution appearance with the registration dossier. Potential effects: complications after intravenous administration, local reactions, risk to treatment safety.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Teikoplanina BRADEX
Risk Level
Critical
Notice Date
28.05.2026

Related

Other Notices